BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 20721783)

  • 1. An extension of Bayesian expected power and its application in decision making.
    Liu F
    J Biopharm Stat; 2010 Sep; 20(5):941-53. PubMed ID: 20721783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sample size and the probability of a successful trial.
    Chuang-Stein C
    Pharm Stat; 2006; 5(4):305-9. PubMed ID: 17128428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Need for speed: an efficient algorithm for calculation of single-parameter expected value of partial perfect information.
    Sadatsafavi M; Bansback N; Zafari Z; Najafzadeh M; Marra C
    Value Health; 2013; 16(2):438-48. PubMed ID: 23538197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Joint equivalence of means and variances of two populations.
    Grieve AP
    J Biopharm Stat; 1998 Jul; 8(3):377-90. PubMed ID: 9741854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian versus frequentist hypotheses testing in clinical trials with dichotomous and countable outcomes.
    Zaslavsky BG
    J Biopharm Stat; 2010 Sep; 20(5):985-97. PubMed ID: 20721786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the value for money of changing clinical practice change: a stochastic application in diabetes care.
    Hoomans T; Abrams KR; Ament AJ; Evers SM; Severens JL
    Med Care; 2009 Oct; 47(10):1053-61. PubMed ID: 19648827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure modeling in occupational hygiene decision making.
    Vadali M; Ramachandran G; Mulhausen J
    J Occup Environ Hyg; 2009 Jun; 6(6):353-62. PubMed ID: 19326267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Bayesian methods for multivariate bioequivalence measures.
    Molina de Souza R; Achcar JA; Martinez EZ
    J Biopharm Stat; 2009; 19(1):42-66. PubMed ID: 19127466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Monte Carlo method for calculating Bayesian uncertainties in internal dosimetry.
    Puncher M; Birchall A
    Radiat Prot Dosimetry; 2008; 132(1):1-12. PubMed ID: 18806256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating and utilizing probability of study success in clinical development.
    Wang Y; Fu H; Kulkarni P; Kaiser C
    Clin Trials; 2013; 10(3):407-13. PubMed ID: 23471634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian random-effects threshold regression with application to survival data with nonproportional hazards.
    Pennell ML; Whitmore GA; Ting Lee ML
    Biostatistics; 2010 Jan; 11(1):111-26. PubMed ID: 19828558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian noninferiority test for 2 binomial probabilities as the extension of Fisher exact test.
    Doi M; Takahashi F; Kawasaki Y
    Stat Med; 2017 Dec; 36(30):4789-4803. PubMed ID: 28960376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decision analysis in forensic science.
    Taroni F; Bozza S; Aitken C
    J Forensic Sci; 2005 Jul; 50(4):894-905. PubMed ID: 16078494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approaches for optimal sequential decision analysis in clinical trials.
    Carlin BP; Kadane JB; Gelfand AE
    Biometrics; 1998 Sep; 54(3):964-75. PubMed ID: 9750245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of model choices for the Continual Reassessment Method in phase I cancer trials.
    Paoletti X; Kramar A
    Stat Med; 2009 Oct; 28(24):3012-28. PubMed ID: 19672839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semiparametric bayesian testing procedure for noninferiority trials with binary endpoints.
    Osman M; Ghosh SK
    J Biopharm Stat; 2011 Sep; 21(5):920-37. PubMed ID: 21830923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of delayed observations on Bayesian decisions for binary data.
    Williamson PP; Choi SC
    J Biopharm Stat; 1998 Nov; 8(4):599-617. PubMed ID: 9855037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementing a decision-theoretic design in clinical trials: why and how?
    Palmer CR; Shahumyan H
    Stat Med; 2007 Nov; 26(27):4939-57. PubMed ID: 17582801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying and reducing uncertainty in life cycle assessment using the Bayesian Monte Carlo method.
    Lo SC; Ma HW; Lo SL
    Sci Total Environ; 2005 Mar; 340(1-3):23-33. PubMed ID: 15752490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-sample Bayesian posterior distributions for probabilistic sensitivity analysis.
    Hazen GB; Huang M
    Med Decis Making; 2006; 26(5):512-34. PubMed ID: 16997928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.